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Purpose/Objective: Since several years, Co-60 HDR afterloading 
sources are commercially available. The long half-life of Co-60 
together with its comparable dose distributions to Ir-192 makes this 
type of sources economically attractive, especially in developing 
countries. However up to date protocols for brachytherapy dosimetry 
provide no explicit guidelines for verification of Co-60 source 
calibration by the clinical physicist. The purpose of this work was 
twofold: first, the verification procedures recommended for Ir-192 in 
three existing dosimetry protocols were applied to both Co-60 and Ir-
192 sources in order to test their applicability with Co-60 sources. 
Second, the evaluation of the experiments was performed together 
with medical physicists trained in a joint education program between 
Universities in Germany and Bangladesh. Purpose of this step was to 
add practical experience in Brachytherapy physics, a subject for which 
the Bangladesh University so far has only very little access to 
treatment facilities. 
Materials and Methods: Three existing dosimetry protocols (IAEA-
TECDOC-1274, DIN 6809-2, AAPM Report 41) were applied to Co-60 and 
Ir-192 sources to measure reference air kerma rate with ionization 
chambers using the procedures recommended for Ir-192. Wherever the 
protocols give no correction factors for the chamber readings from Co-
60 sources, equivalent factors from literature were used. Verification 
measurements were performed with three different experimental 
methods (with a cylindrical ionization chamber both in a solid 
phantom and free in air, and with a well chamber) and evaluated with 
all three protocols. The measurements were performed at two 
hospitals in Germany, and evaluated in parallel in by the groups in 
Germany and Bangladesh. The results are compared to the reference 
air kerma rates given in the source certificates. 
Results: The measurements with all protocols and methods are in 
good agreement both for Ir-192 and Co-60. The measured air kerma 
rates show deviations from the certificate values smaller than 1.2% for 
Ir-192 and 2.5% for Co-60-Sources. The measurements with the well 
chamber show the lowest deviations from the certificate value. The 
results of the experiments were published both in a German and in an 
Indian medical physics journal. 
Conclusions: Air kerma rate measurements for Co-60 HDR sources 
using the existing protocols are possible with accuracy sufficient to 
verify source calibration even though the protocols are not specifically 
designed for Co-60 measurements. The existing protocols for 
brachytherapy dosimetry are outdated. New protocols are desirable, 
based on measurements with ionization chambers calibrated in 
absorbed dose to water and providing the complete measurement 
procedure and correction formalism also for Co-60 sources. Joint 
evaluation of experiments by physicist at a teaching institution and 
physicists in training at a second institution can provide a valuable 
means to disseminate experience to institutions with missing 
experimental resources. 
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Purpose/Objective: A water equivalence study of different human 
tissue compositions is interesting to validate the segmentation 
schemes employed in contemporary treatment planning systems with 
advanced dose calculation algorithms, and assist their benchmarking 
against TG43 based calculations in water. 
Materials and Methods: Monte Carlo simulations were performed for a 
point 192Ir source centered in homogeneous 50cm radius spheres of 
different tissue compositions taken from Schneider et al (2000) and 
the AAPM TG186 report. Tissue density was set to 1 in all simulations. 
Dose was approximated by collision kerma and both water and tissue 
kerma in tissue (i.e. Kw,t and Kt,t) were scored using the *F2 surface 
flux tally. Results are expressed as % differences of Kw,t with 
homogeneous water (Kw,w) to quantify differences in attenuation and 
scatter, as well as % differences between Kt,t and Kw,w to quantify 
the combined effect of the attenuation and differences in mass 
energy absorption. 
Results: 
 
  
When the effect of density is ruled out, differences in electron density 
and Zeff between air and water translate to negligible differences in 
attenuation (Kw,air is within 1% with Kw,w in contrast to Kair,air 
which is 10% lower due to the lower mass energy absorption of air). 
Dosimetric differences between lung and water are negligible 
regardless of kerma reporting in lung or water, albeit positive in the 
former case and negative in the latter. For soft tissue materials, Kw,t 
reporting would yield significant differences from water for high 
adipose content (lower O weight) only at increased distances. Kt,t 
reporting would yield negligible differences from water for all 
materials and distances. The connective and mean soft tissues all 
appear dosimetrically equivalent to water regardless of reporting Kw,t 
or Kt,t, except for mean adipose. Skeletal tissues present increasing 
differences from water with increasing proportion of osseous tissue to 
bone marrow, with negative differences for Kw,bone and positive for 
Kbone,bone. 
Conclusions: Lung and average soft tissue materials set forth by the 
AAPM TG186 are water equivalent for the 192Ir energies regardless of 
kerma reporting material. Departure from water equivalence is only 
observed when Kw,t is reported and only for large tissue thickness. 
Kerma reporting material also affects the differences relative to 
water for skeletal materials. Tissue density is the determining 
parameter for individualized 192Ir patient dosimetry. A method for 
stoichiometric CT calibration is not required unless reporting water 
kerma in the inhomogeneous geometry is of the essence. 
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Purpose/Objective: In permanent I-125 seed implants of the prostate, 
the quality of the implant depends, amongst other factors, on the 
quality of the image modality used during implantation. The image 
modality most frequently used in the OR is TRUS. Since March 2009 a 
new type of TRUS probe is introduced in our clinic. This is a dual 
sagittal crystal probe (DSCP) with a transversal crystal in between, 
instead of the conventional single sagittal crystal probe (SSCP) with a 
transversal crystal in front. In a retrospective study it was 
investigated whether a longer sagittal view using a DSCP allowed for 
more accurate online-planning in I-125 permanent implant 
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brachytherapy of the prostate, compared to a SSCP. The primary 
objective of this study was to investigate whether a DSCP leads to 
more similarity between an online plan based on TRUS and a post plan 
based on CT, compared with SSCP. The secondary objective was to 
determine whether the post-plan based DVH parameters improved 
using with the DSCP technique compared with the SSCP technique. 
Materials and Methods: In the study 50 consecutive patients with 
prostate cancer were included, who were treated between March 
2008 and March 2010. The first 25 of these patients had their online 
planning based on a SSCP, the plans of the other 25 patients were 
based on a DSCP TRUS. Three weeks after implantation a post 
planning was made based on CT. TRUS online and CT post plan dose 
volume histogram (DVH) parameters, D90 and V100, were compared 
for both groups. Also, the post plan DVH parameters of SSCP were 
compared with DSCP. The possible factors that might influence the 
post plan D90 and V100 were analysed using ANOVA. 
Results:  
 The SSCP and DSCP online mean D90 and V100 were significantly 
larger than post plan mean D90 and V100 (P < 0.01). The post plan 
mean D90 and mean V100 were both non-significantly larger for the 
with SSCP implanted patients, compared to the with DSCP implanted 
patients (P = 0.76 and P = 0.68).  The online-plan D90 and V100 in the 
DSCP group were very similar among the patients, compared to the 
SSCP group. The SD's of the D90 of SSCP and DSCP were 14.2 Gy and 
11.1 Gy and the V100 ranged from 91.5 to 99.1% and from 97.7 to 
99.9%, respectively. ANOVA showed significant impact of prostate 
volume on the post-plan D90 (P<0.01) and V100 (P = 0.02). 
Conclusions: The longer sagittal view of the prostate and surrounding 
tissues with the DSCP enabled better visualisation in one view, which 
resulted in more homogeneous online plans among patients. However, 
the DVH parameters showed that this did not lead to more accurate 
online planning. The TRUS and CT based D90 and V100 showed 
statistical significant difference, whereas the post plan based D90 and 
V100 did not improve with the DSCP technique compared to the SSCP 
technique. Both types of probes are equally accurate for permanent 
prostate brachytherapy treatment planning. The most important 
factor found to influence DVH parameters was the prostate volume. 
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Purpose/Objective: In 3-Tesla MRI image, the seeds and the contours 
of prostate and urethra are clearer than in 1.5-Tesla MRI image. 
Meanwhile, their reliability has been less investigated, and it remains 
unclear which procedure is more reliable. We assessed the 
interobserver variability in 3-Tesla and 1.5-Tesla MRI/CT fusion-based 
postimplant dosimetry of prostate brachytherapy. 
Materials and Methods: Between July 2009 and December 2010, a 
total of 26 consecutive prostate cancer patients underwent 
brachytherapy and 1.5-Tesla MRI and CT (1.5T) were performed on 
day 30. Subsequently, between December 2010 and November 2011, 
another  26 consecutive prostate cancer patients underwent 
brachytherapy and  3-Tesla MRI and CT (3T) were performed on day 
30. All the patients were treated with 144 Gy of brachytherapy alone. 
Two radiation oncologists performed MRI/CT fusion-based postimplant 
dosimetry. The interobserver variability of dose-volume histogram 
(DVH) parameters (prostate D90, prostate V100, prostate V150, 
urethral D5, and urethral V200) was calculated by using Pearson’s 
correlation coefficients. Differences in means of DVH parameters were 
also tested by using a paired t test. 
Results: Pearson’s correlation coefficients of 3T were larger than 
those of 1.5T in all the DVH parameters (prostate D90, 1.5T: 0.66, 3T: 
0.85; prostate V100, 1.5T: 0.63, 3T: 0.68; prostate V150, 1.5T: 0.96, 
3T: 0.98; urethral D5, 1.5T: 0.84, 3T: 0.92; urethral V200, 1.5T: 0.77, 
3T: 0.92). In a paired t test, none of the DVH parameters were 
statistically significant in 3T (0.082≤p≤0.26). In 1.5T, however, 
significant differences were observed in prostate D90, prostate V100, 
and prostate V150 (p<0.001). 
Conclusions: The interobserver variability of 3-Tesla MRI/CT fusion-
based postimplant dosimetry was smaller than that of 1.5-Tesla 
MRI/CT fusion-based postimplant dosimetry, suggesting that the 
former is more reliable among prostate cancer patients undergoing 
brachytherapy. 
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Purpose/Objective: The electromagnetic tracking systems 
(EMTS),initially employed in virtual reality experiments, are more and 
more integrated in several medical protocols. That technology can 
improve the accuracy of physician's gestures from real time tracking 
of positions and orientations of needles or catheters. However, the 
electromagnetic field distortion, due to metallic structures or medical 
devices in the environment, is not negligible and has to be 
characterized. For prostate brachytherapy, there are several metallic 
elements and electronic tools close to the zone of detection: the 
operating table, the needles, the template, the ultra-sound probe 
stabilizer and an important concentration of small seeds in volume of 
interest during low-dose rate (LDR) brachytherapy. The purpose of 
this study is to characterize the performance of the planar field 
generator Aurora (Northern Digital Inc., Waterloo, Canada) as a real-
time, high accuracy needle guidance technology in prostate 
brachytherapy.  
Materials and Methods: All measurements have been recorded in an 
environment free of electromagnetic disturbances. The 
characterization of the planar field generator Aurora from NDI 
included the definition of volume boundaries, the errors calculations 
of position and orientation for the sensor throughout this volume.For 
these measurements the sensor (5 degrees of freedom (5DOF)) was 
integrated into a needle from a biopsy introducer set (PHILIPS 
developed EM system). The needle support could be moved accurately 
with a sub-millimeters displacement (± 0.25mm) everywhere in the 
measurement volume (600 x 600 x 600 mm³) in front of the generator. 
To estimate the accuracy of position, 486 measurements were 
recorded into the volume of interest. In addition, 22 measurement 
points, covering from X to Y degrees, were utilized to evaluate the 
accuracy of orientation measurements. The latter were repeated for 
needle orientations parallel (± 90°)and perpendicular (0°) to the 
central axis of the field generator. 
Results: Results show that the standard deviation on sensor position is 
less than 0.04 mm when needle is located within 26 cm of 
generator,but start increases significantly beyond 35 cm. When needle 
is on volume edges(at 60 cm) the position defined by EMTS is 
underestimated by 16.0±0.6 mm. The errors on the measured 
orientation were low at ±1°, except when the needle is perpendicular 
to the generator, at more than 375 (±1) mm; the error on the 
orientation rises exponentially with distance up to 4.5° at 575 (±1) 
mm. 
Conclusions: Our work shows that the EMTS Aurora planar field 
generator seems to possess the needed accuracy to enable real-time 
needle/catheter guidance for brachytherapy applications. As 
recommended practices, the needle should be parallel with the 
generator plan, and the treatment zone should be ideally kept within 
  
 
 
  
 
